You are here

Pharma CEOs

Pharma CEOs press case against drug price negotiation as bill gains support

BioPharma Dive

Thu, 08/4/22 - 06:28 pm

Sanofi CEO Paul Hudson says his company is the Big Pharma 'least exposed' to generics this decade

Fierce Pharma

Thu, 07/28/22 - 12:23 pm

Roche CEO Severin Schwan to step down after 14 years

Pharmaforum

Thu, 07/21/22 - 10:42 am

Thomas Schinecker

Joe Papa resigns as chair of Bausch Health as billionaire John Paulson takes over

Endpoints

Fri, 06/24/22 - 10:39 am

In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around

Fierce Biotech

Thu, 06/23/22 - 10:54 am

Pascal Soriot wouldn't 'do anything differently' in Covid-19 vaccine development — report

Endpoints

Tue, 06/7/22 - 10:09 am

A ‘perfect storm’ of world calamities may bring down drug prices, Takeda CEO says

Fierce Pharma

Thu, 06/2/22 - 10:28 am

Christophe Weber

Knighthood for AstraZeneca's Pascal Soriot

Spectator Australia

Thu, 06/2/22 - 10:18 am

Passage Bio CEO Bruce Goldsmith Abruptly Steps Down

BioSpace

Wed, 06/1/22 - 07:34 pm

Bruce Goldsmith

Pfizer-partnered Zentalis woos new CEO, cobbles together $200M

Endpoints

Mon, 05/16/22 - 07:37 pm

Seagen CEO Siegall resigns after domestic abuse arrest

Fierce Pharma

Mon, 05/16/22 - 10:40 am

domestic violence

Domestic abuse arrest of Seagen CEO came during a hazy night of booze, sex and violence: police report

Fierce Pharma

Wed, 05/11/22 - 10:55 pm

domestic violence

Seagen CEO Clay Siegall put on leave amid domestic violence investigation

Fierce Pharma

Mon, 05/9/22 - 10:06 am

domestic violence

FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return

Fierce Pharma

Wed, 05/4/22 - 05:46 pm

Next Biogen CEO's most-prized expertise? Dealmaking experience, investors say

Fierce Pharma

Wed, 05/4/22 - 05:34 pm

Vounatsos Out as Biogen Appears to Concede Defeat Over Aduhelm

BioSpace

Tue, 05/3/22 - 10:52 am

Michel Vounatsos

Biogen CEO's 2021 pay remains level despite Aduhelm tribulations

Fierce Pharma

Fri, 04/29/22 - 10:38 am

Michel Vounatsos

More program cuts ahead as Sanofi CEO Paul Hudson continues to reshape the company

Endpoints

Thu, 04/28/22 - 10:41 pm

Y-mAbs' longtime CEO steps down abruptly as FDA reviews second pediatric cancer drug

Endpoints

Thu, 04/28/22 - 11:01 am

Y-mAbs Therapeutics

Regeneron CEO's pay drops 95%—but that shouldn't come as a shock

Fierce Pharma

Fri, 04/22/22 - 10:28 am

Leonard Schleifer

Pages